Israel‘s largest healthcare provider on Sunday reported a 94 per cent drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.Health maintenance organization (HMO) Clalit, which covers more than half of all Israelis, said the same group was also 92 per cent less likely to develop severe illness from the virus.
Japan approves its 1st coronavirus vaccine, set to begin inoculations within days The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]“It shows unequivocally that Pfizer’s coronavirus vaccine is.